Effects of Curcumin and Pentagamavunon-0 Against Dengue-2 Virus Infection in Vero Cells; an in Vitro Study  by Marbawati, Dewi & Umniyati, Sitti Rahmah
 Procedia Environmental Sciences  23 ( 2015 )  215 – 221 
1878-0296 © 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of scientific committee of the ICTCRED 2014
doi: 10.1016/j.proenv.2015.01.033 
Available online at www.sciencedirect.com
ScienceDirect
International Conference on Tropical and Coastal Region Eco-Development 2014         
(ICTCRED 2014) 
Effects of Curcumin and Pentagamavunon-0 Against Dengue-2 
Virus Infection  In Vero Cells; an In Vitro Study 
 
Dewi Marbawatia,*, Sitti Rahmah Umniyatib 
a,* aVector Borne Disease Control Research and Development Office in Banjarnegara, Selamanik Street Banjarnegara 53415, Indonesia 
bDepartemen of Parasitology, Faculty of Medicine, Universitas Gadjah Mada, Sekip Utara, Yogyakarta,55281, Indonesia 
Abstract 
The research aims was to determine the cytotoxic effects and the highest safe concentration of curcumin and PGV-0 
on vero cells. This research also compare the effect of curcumin and PGV-0 against vero cells infected by Dengue 
virus (in vitro) in one and three days incubation period. The highest safe concentrations against vero cells from 
curcumin was 6.25 ppm and 1.5625 ppm for PGV-0. Immunocytochemistry test of curcumin and PGV-0 in both 
incubation period (one and three days) shows no significant difference (significant value 0.925), but RT-PCR result 
indicates that PGV - 0 have potential antiviral better than curcumin. 
© 2014 The Authors. Published by Elsevier B.V.  
Peer-review under responsibility of scientific committee of the ICTCRED 2014. 
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1. Introduction 
Dengue Haemorrhagic Fever (DHF) is an infectious disease caused by dengue virus. Dengue is still a 
significant health problem in tropical and sub tropical countries, because the course of this disease was very fast, so 
if not addressed promptly, it can be fatal. The global prevalence of dengue infection has increased dramatically in 
recent decades. Dengue infection has now become an endemic in more than 112 countries in Africa, America, 
Eastern Mediterranean, Southeast Asia and Western Pacific. The World Health Organization (WHO) estimates that 
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40% of the world’s population or 2.5 billion people live in tropical and subtropical areas at risk for contracting the 
Dengue infection [1, 2]. 
Dengue virus is an RNA virus which is included in Flaviviridae family [3], infecting 50 to 100 million 
people per year. However, a vaccine which is commercially available has not been found as it is still in the 
development stage; specific therapy or effective antiviral drugs to treat dengue virus infection has also not been 
found yet. As a result, the development of antiviral drugs licensed for the treatment of patients remains an urgent 
need to prevent Dengue deaths. 
Indonesia has many traditional medicinal plants that have been reported to have potent antiviral activity and 
a few have been used to treat people infected with Dengue. Examples of these are Curcuma longa plant which has 
curcumin content, that is, a yellow chemical compound especially on the roots of plants. Some studies suggest 
curcumin has preventive activity against viral agents, such as vasicular stomatitis (VSV), HSV 1 and 2, 
parainfluenza-3, reovirus-1, feline corona virus, feline herpes virus and other viruses with EC50 0.019 to 0.105 μM 
[4]. Curcumin is also known to perform the inhibition of ubiquitin-proteasome system that causes a decrease in the 
production of one type of flavivirus which is Japanese encephalitis from neuroblastoma cells which are previously 
infected [5]. 
Curcumin has anticancer, antimutagenic, anticoagulant, antifertility, antidiabetic, antibacterial, antifungal, 
antiprotozoa, antivirus and antifibrosis activities [6]. Based on the analysis of the structure of curcumin, it is known 
that the pharmacological activities of curcumin are related to functional groups such as double bonds in the middle 
of the chain, β-diketon group, and fenolik  hydroxy groups [7]. A study on relationship of structure to curcumin 
activity has been done by Sardjiman (1997) on the cell lines [8]. One of curcumin analogue compounds that have 
received patents as an anti-inflammation and introduced as a National Molecule (Molnas) is pentagamavunon-0 
(PGV-0). PGV-0 compound [2,5-bis-(4' - hydroxy-3'- metosksibenzilidin)-cyclopentanone] is known have 
antioxidant and anti-inflammatory potential which is more powerful and less toxic than other curcumin analogue 
compounds [9] and has never been tested in vitro activity as antiviral. Accordingly, this study was conducted to 
determine the effects of curcumin and pentagamavunon-0 against Dengue-2 virus Infection. 
The method used for the detection of Dengue virus in this study was RT-PCR and immunocytochemistry. 
Both examination techniques are known to have a high sensitivity; thus, it can detect the antigens with low levels. 
RT-PCR technique is known rapid and sensitive for the detection of viral RNA, but this method is expensive and 
requires certain tools and skills, whereas immunocytochemistry has the advantage of requiring no special equipment 
and can be done only by using a light microscope widely available in laboratories and requiring no certain skills  
 
Nomenclature 
DHF  Dengue Haemorrhagic Fever 
WHO  World Health Organization 
RNA  Ribonucleic Acid 
VSV  Vasicular Stomatitis 
PGV-0  Pentagamavunon-0 
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2. Method 
This was a laboratory experimental study. Curcumin (1,7-bis (4'hidroksi - 3 methoxyphenyl)-1,6 heptadien, 
3,5-dione) used Sigma brand, whereas curcumin analogue compound (PGV-0 or 2,5-bis- (4-hydroxy-3-
metoksibenzilidin) cyclopentanone) was obtained from synthesis results in the pharmaceutical laboratory of UGM. 
Five mg of  each compound was dissolved in 100 μl dimethyl sulfoxide (DMSO) as stock solution.  
Cytotoxic test were carried out using the MTT [3 - (4,5-dimetiltiazol-2-i1) -2,5 difeniltetrazolium bromide]. 
Cells at a density of 104 vero cells / wells distributed in wells (well plate) and incubated for 24 hours. Followed by 
the addition of curcumin and PGV-0 with 7 (seven) concentration series of 50, 25, 12.5, 6.25, 3.125, 1.5625 and 
0.78125 ppm respectively - each of 4 replications. Solvent used to dissolve the test compound is dimethylsulfoxide 
(DMSO). The cytotoxicity test results read by Elisa reader with a wavelength of 595 nm.  
Immunocytochemistry test SBPC.  
Vero cell culture at a density of 5 x 105 cells per well were grown in a well plate . Each given a deck glass 
that has been coated with poly elysin as the attachment of cells . Well plate is divided into two (2) incubation of the 
incubation groups (1) and three (3) days . Each group was divided into groups of Dengue - 2 virus infected 1 day 
incubation and were given curcumin, the positive control (cells infected by dengue 2 days of incubation 1) and cells 
infected by Dengue - 2 incubation 1 day but not given immunocytochemistry staining of primary antibody DSSE10 
as immunocytochemistry control, and negative control (uninfected cells 1 day incubation). The division of the group 
on the infected cell for three (3) days is similar to that of Dengue - 2 infected incubation one (1) day. 
Immunocytochemistry examination SBPC [10] . 
Sample to be tested were fixed with cold methanol and washed with PBS. The slide then immersed in 
peroxidase blocking solution at room temperature for 10 minutes, to remove endogenous peroxidase activity, then 
washed with distilled water. Sample incubated in the background sniper (protein blocking solution) for 10 min at 
room temperature. Primary antibodies (monoclonal antibodies DSSE10 1:10) was added 100 mL per preparation 
(adjusted until all parts were flooded) and then incubated in a moist tray overnight. Preparations then washed with 
PBS for 2 x 2 minutes. Trekkie universal link (secondary antibody) was added to 30 mL per preparations and 
incubated at room temperature (250 C) for 15 minutes and washed with PBS for 2 x 2 minutes. Trekavidin - HRP 
reagent was added and incubated for 10 minutes, then washed with PBS for 2 x 2 minutes . 
Substrate preparation is done with DAB chromogen : DAB chromogen betazoid 1 mL diluted with 100 mL 
betazoid susbtrate DAB buffer immediately before use. Sample incubated in DAB chromogen substrate above 30 
mL per sample for 10 minutes, then washed with tap water. Cat Mayer hematoxylin (counterstain) was added to the 
preparations, and then incubated for 1-3 minutes, then washed under tap water and dried. Furthermore, dipped in 
alcohol, dried and cleaned and then covered with spilled entellan cover glass. Ready to be examined under a 
microscope at a magnification of 40x , 100x , 400x and 1000x. Cell preparations showed a brown color at the 
cytoplasm or contained brown granules around the cell means Dengue - 2 antigen positive, whereas cells showed 
blue or pale and there are no brown granules around the cell as a negative control. Results of Immunocytochemistry 
examination positive rate result was analyzed by ANOVA with Confidence Interval ( CI ) 95 % .  
RT – PCR (Polymerase Chain Reaction)  
RT-PCR examination begins with the extraction of RNA / RNA isolation of dengue virus with the manual 
High Pure Viral Nucleic Acid Kit (Roche Diagnostics GmbH, Mannheim Germany, cat no.11 858 874 001). The 
PCR process using RT-PCR (Superscript ™ Kit, III One Step RT-PCR System with Platinum, Invitrogen 125 74-
026). Serotype-specific primers used were:  
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Table 1. Primer for One-Step RT-PCR (Yong et al., 2007) [11] 
Virus 
Serotype  
Primer Primer Sekuens  Primer Position  Band 
Target 
 Dcon 5’- AGT TGTTAGTCTACGTGGACCGACA-3’ 1-25  
DEN 2 D2  5’- CGCCACAAGGGCCATGAACAG-3’ 231-251 251 bp 
PCR mix was made in tubes of 1.5 ml nuclease - free and done in the ice with: 2x reaction mix 12.5 mL, 
SuperscriptTMIII RT / Platinum ® Taq Mix as much as 0.5 mL, MgSO4 as much as 0-2 mL, primary Dcon 
(forward) in 1 mL, D2 primer (reverse) by 1 mL, RNase- free water as much as 0-3 mL and RNA as much as 5-10 
mL, total volume of about 25 mL. The components were confirmed to the bottom of the tube by means of 
centrifugation. PCR mix put in a thermal cycler, then its run according to the program : (i) cDNA synthesis 1 cycle : 
600C for 45 min; (ii) predenaturasi 1 cycle : 940C for 2 min; (iii) 30-35 amplification cycles: 940C for 30 sec 
(denaturation), 600C for 30 sec (annealing), 680C for 1 min (extension); (iv) final extension of 1 cycle : 680C for 5 
minutes . RT - PCR products generated electrophoresed on 1.5% agarose gel and the 100 bp ladder used as a marker 
to analyze the products of PCR. The expected size band is 251 bp. 
3. Results and Discussion 
3.1. Cytotoxicity test of curcumin and PGV-0 
The cytotoxic test of curcumin and PGV-0 used seven concentrations; 50, 25, 12.5, 6.25, 3.125, 1.5625 and 
0.78125 ppm. Solvent used to dissolve the test compound was dimethylsulfoxide (DMSO). Observation of living 
cells was performed with MTT method. MTT was used to evaluate cytotoxic changes of a compound based on 
tetrazolium salt into a colored product (formazan) by the dehydrogenase succinate mitochondrial enzyme with the 
help of cellular NADH. Living vero cell percentages were calculated based on a comparison between the treatment 
absorbance of the test compound and the vero cell controls. The percentage of living vero cells after administration 











Fig 1. Percentage of living vero cells after curcumin and PGV–0 treatment. 
The result of the cytotoxic test for curcumin was 6.25 ppm and PGV-0 was 1.5625 ppm. Both 
concentrations were obtained from the calculation of the percent of living cells over 100%. Cytotoxicity potential of 
PGV-0 was higher than curcumin. It’s seen from a safe concentration value of vero cells for PGV-0 was smaller 
than curcumin. Increased cytotoxicity potential of PGV - 0 was likely due to changes in β - diketon groups on 
curcumin into cyclopentanone group, leading to increased cytotoxicity activity against vero cells. 
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3.2. Immunocytochemistry to Determine Antiviral Ability of curcumin and PGV-0 
The result of immunocytochemistry test on vero cells infected with Dengue-2 virus on first day incubation 
and treated using curcumin and PGV-0 is as follows:  
Table 2 . Positive rate of  immunocytochemistry test on vero cells infected by Dengue-2 virus on first day incubation. 









Immunocytochemistry test results  on third day incubation shown in the following table: 
Table 3. Positive rate of  immunocytochemistry test on vero cells infected by Dengue-2 virus  on third day incubation 
    Compound 
    Curcumin PGV-0 Positive Control 
Repeat 1 MP % 2 ± 1.25 3.3 ± 3.23 18.6 ± 11.2 
P % 2.6 3.43 20.4 
N % 97.4 96.57 79.6 
Repeat 2 MP % 6.6 ± 3.27 4.2 ± 4.75 10.5 ± 3.3 
P % 7.6 4.23 14.48 
N % 92.4 95.77 85.52 
Repeat 3 MP % 2 ± 1.56 3.9 ± 3.69 
P % 2.11 4.51 
N % 97.88 95.49 
Average MP % 3.53 ± 2.03 3.8 ± 3.89 14.55 ± 7.25 
P % 4.1 4.06 17.44 
N% 95.89 95.94 82.56 
Description: MP=mean positive, P=positive, N=negative 
Compound 
Curcumin PGV-0 Positive control 
Repeat 1 MP % 9.1 ± 5.19 5.6 ± 8 13.7 ± 8.14 
P % 9.3 7.7 20.3 
N % 90.7 92.3 79.7 
Repeat 2 MP % 16.7 ± 10 18.5 ± 14.79 29.3 ± 18.37 
P % 5.73 18.05 28.2 
N % 84.27 81.95 71.8 
Repeat 3 MP % 15.1 ± 10.33 11.1 ± 5.74 
P % 15.24 12.8 
N % 84.76 87.2 
Average MP % 13.63 ± 8.506 11.73 ± 9.48 21.5 ± 13.25 
P % 10.09 12.85 24.25 
N % 86.57 87.15 75.75 
     
Description: MP=mean positive, P=positive, N=negative 
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Anova test results on a comparison of positive rate of curcumin and PGV-0 both on first and third day 
incubation obtained significance value (0.925). Thus, it’s known that there was no significant difference between 
curcumin and PGV-0 treatment from first and third day incubation (the ability of curcumin and PGV-0 in lowering 
the positive rate of Dengue virus infection was the same). 
Results of statistical test on positive rate calculation showed that the ability of curcumin and PGV - 0 in 
lowering the positive rate of Dengue virus infection was the same. However, when compared with the positive rate 
of positive control (cells infected with Dengue-2 virus but not treated with the test compound), it is known both 
curcumin and PGV-0 could reduce the positive rate due to Dengue virus infection. 
Research of Nurminha (2011), immunocytochemistry test with WDSSB5 antibodies obtained positive rate 
100 % on C6/36 cells infected by Dengue-3 virus [12] . In cells infected with positive rate of 100 %, strong positive 
reaction of brown color was very clear in the cytoplasm of cells, many giant cells and irregular cell shape. 
3.3. Reverse Transcription Polymerase Chain Reaction (RT-PCR) 








Fig 2. Photo of electrophoresis results of RT-PCR products from vero cells infected with Dengue-2 virus and treated with curcumin and PGV-0. 
M : 100 bp ladder marker, K : positive control of Dengue-2 virus, Lane 1: negative control of first day incubation (without infection), Lane 2: 
positive control of Dengue-2 virus on first day incubation, Lane 3 : first day incubation treated with curcumin, Lane 4: first day incubation treated 
with PGV-0, Lane 5: negative control of third day incubation, Lane 6 : positive control of Dengue-2 virus  on third day incubation, Lane 7: third 
day incubation treated with curcumin, Lane 8: third day incubation treated with PGV-0. 
RT-PCR examination could detect Dengue-2 virus in vero cells infected in the incubation period of day 3 
(viral positive control) and a treatment sample on day three of viral infections treated with curcumin. In day 1 
infection, both viral control and treatment with curcumin and PGV-0 had not seen any positive antigen of dengue-2 
by RT-PCR examination. 
Comparison of the results of RT-PCR and immunocytochemistry showed that immunocytochemistry test 
could detect Dengue-2 antigen in the first incubation period, while the results of first day incubation using RT-PCR 
was negative. Research by Harris [13] suggested that the detection of RNA Dengue could be performed on Ae. 
aegypti individually using One Step RT-PCR from the first day after viral inoculation. At the study, Ae.aegypti was 
infected parenterally with Dengue-2 virus with a titer of 103 PFU. According to Jittmittraphap [14] , PCR was able 
to detect the RNA virus in the mosquito's body with an incubation period of 7 days with a titer of 1-10 PFU. 
Research of Widiastuti [15] stated that RNA from Dengue-3 virus in infectious mosquito on 1- 4 day incubation 
could not be detected using RT-PCR, although the concentration of RNA was performed; Dengue-3 virus RNA 
could be detected after 5 day incubation. Yasmon [16] stated that a false negative on RT-PCR examination could be 
caused by the number of viral particles in the sample which was too low. 
Positive results of Dengue-2 antigens shown in the third day incubation of curcumin treatment. Mean while 
incubation of Dengue-2 virus infection treated with PGV-0 in third days  was negative. This suggested that the 
PGV-0 have a Dengue-2 antiviral better than curcumin. This was possible because there was a major difference 
between curcumin and PGV-0 on the central cluster chemical structure. Removal of the active methylene group and 
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the carbonyl group at the center of the structure of curcumin led to be non-polar, so it became more soluble in lipid 
and was more easily interact with the walls of bacteria and viruses. So that from this research the PGV-0 is more 
potent than curcumin as Dengue antivirus. 
4. Conclusions  
PGV-0 was more toxic than curcumin to the vero cell and the comparison effect of curcumin and PGV-0 on vero 
cells in first and third day incubation by Dengue-2 infection showed that the result of positive rate was not 
significantly different (from immunocytochemistry test). The results of RT-PCR showing positive Dengue-2 antigen 
only on day 3 of curcumin treatment, which indicated that PGV-0 had better antiviral activity against Dengue-2 
compared to curcumin. 
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